None listed
Conditions
Interventions
Others(Digital therapeutics) : Subjects were advised to use NUROW (AIMMED Co., Ltd., Seoul, Korea) for at least 15 minutes everyday, total of 4 weeks. NUROW includes Go/No-go Task and N-Back/Updating
Sponsors
CHUNGNAM NATIONAL UNIVERSITY SEJONG HOSPITAL
Eligibility
Sex/Gender
All
Inclusion criteria
Inclusion criteria: Subjects from child psychiatry outpatient clinic, with ages 6 to 12 who were diagnosed with ADHD by Kiddie-Schedule for Affective Disorders and Schizophrenia-Present and Lifetime Version (K-SADS-PL) were recruited. With all written consents given, subjects and their caregivers who have heard and fully understood the detailed explanations of this study and have voluntarily decided to participate were included.
Exclusion criteria
Exclusion criteria: Participants with intellectual disability, Autism Spectrum Disorder(ASD), organic brain diseases, congenital hereditary diseases, and any seizure or neurological disorders were excluded. Participants who were taking antidepressants, antipsychotics, and anxiolytics were also excluded due to any possible neurocognitive effects within 2 weeks of the recruitment.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| ADHD rating scale (ARS) | — |
Secondary
| Measure | Time frame |
|---|---|
| Childhood Behavior Checklist;Comprehensive Attention Test;Corsiblock test;Stroop test;Simon task;Wisconsin Card Sorting Test | — |
Countries
Korea, Republic of
Contacts
Public ContactSoojeong Kwon
CHUNGNAM NATIONAL UNIVERSITY SEJONG HOSPITAL
Outcome results
None listed